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ABSTRACT
Introduction Most patient- reported outcome measures 
(PROM) for chronic wounds are specific to a single wound 
type (eg, pressure ulcer) or part of the body. A barrier 
to outcome assessment in wound care and research 
is the lack of a rigorously designed PROM that can be 
used across wound types and locations. This mixed 
method study describes the protocol for an international 
collaboration to develop and validate a new PROM called 
the WOUND- Q for adults with chronic wounds.
Methods and analysis In phase I, the qualitative 
approach of interpretive description is used to elicit 
concepts important to people with wounds regarding 
outcome. Participants from Canada, Denmark, the 
Netherlands, and the USA are aged 18 years and older 
and have a wound that has lasted 3 months or longer. 
Interviews are digitally recorded, transcribed and coded. 
A conceptual framework and preliminary item pool are 
developed from the qualitative dataset. Draft scales are 
formed to cover important themes in the conceptual 
framework. These scales are refined using feedback from 
people with chronic wounds and wound care experts. 
After refinement, the scales are translated into Danish 
and Dutch, following rigorous methods, to prepare for 
an international field- test study. In phase II, data are 
collected in Canada, Denmark, the Netherlands, and 
the USA. An international sample of people with a large 
variety of chronic wounds complete the WOUND- Q. Rasch 
Measurement Theory analysis is used to identify the best 
subset of items to retain for each scale and to examine 
reliability and validity.
Ethics and dissemination This study is coordinated at 
Brigham and Women’s Hospital (Boston, USA). Ethics board 
approval was received at each participating site for both 
study phases. Findings will be published in peer- reviewed 
journals and presented at national and international 
conferences and meetings.
InTRoduCTIon
Each year, millions of individuals require treat-
ment for chronic wounds. A recent systematic 
review of 11 studies reported a prevalence in 
the general population to be 2.21 and 1.51 
per 1000 population for wounds of mixed 
aetiology and chronic leg ulcers respectively.1 
Wound care has a huge economic impact on 
healthcare systems worldwide. An analysis of 
US Medicare claims for 2014 showed that 15% 
of beneficiaries (8.2 million) had an episode 
of care for a chronic wound or infection, with 
costs estimated between 28.1 and 96.8 billion.2 
In the UK, a study estimated that 4% of the 
total expenditure by the National Health 
Service in 2012/13 (5.3 billion pounds) went 
towards managing chronic wounds and asso-
ciated morbidity for 2.2 million patients.3
Chronic wounds have many different 
causes and numerous treatment modali-
ties. The Cochrane Wounds review group, 
established in 1995, lists more than 150 
protocols and reviews of the effects of inter-
ventions to prevent and treat wounds and their 
Strengths and limitations of this study
 ► Recruitment of an international sample makes it 
possible to develop a patient- reported outcome 
measure (PROM) that reflects the concerns of pa-
tients in multiple countries.
 ► Including people with varying types of chronic 
wounds in different locations on the body ensures 
that the WOUND- Q is broadly applicable.
 ► We adhere to published guidelines for PROM devel-
opment, including rigorous methods for translation 
and cultural adaptation.
 ► We use a modern psychometric approach (Rasch 
Measurement Theory) to enhance the interpretability 
of WOUND- Q scores.
 ► A limitation of our study is that patient involvement 
does not include membership in the research team. 
Another limitation is that the WOUND- Q field- test 
takes place only in high- income countries.
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complications.4 Outcome measures used in intervention 
studies tend to involve the use of objective measures (eg, 
healed wounds, rate of healing, and adverse effects). The 
inclusion of carefully designed patient- reported outcome 
measures (PROMs) that ask about concerns that matter 
the most to patients, including bothersome symptoms, 
such pain, exudate and odour, and the impact of wounds 
on aspects of quality of life, can provide important 
additional information from the patient perspective. 
Cochrane reviews of wound treatments show that such 
outcomes are often overlooked in treatment studies.5–8.
PROMs that measure outcomes that matter to patient, 
as well as their experience of healthcare, are increas-
ingly used to inform quality improvement initiatives, 
patient care, and comparative effectiveness research.9–11 
In chronic wounds, four reviews of PROMs have been 
published.12–15 These reviews report that generic tools 
(eg, SF-36, EQ- 5D, and Nottingham Health Profile) are 
often used. Such tools are limited in terms of content 
validity as they fail to ask about important wound- specific 
issues (eg, odour and exudate). In terms of wound- 
specific PROMs, most were developed for a specific type 
of wound, including venous leg ulcers,16–22 foot ulcers,23 24 
and pressure ulcers,25 26 or for wounds on specific parts of 
the body.27 The Wound- QoL28 (Questionnaire on quality 
of life with chronic wounds) represents an exception, 
as it was designed for all types of chronic wounds. This 
17- item instrument, published in 2014, was developed 
by taking items from three existing PROMs, using factor 
analysis to determine how the items group together, and 
then attaching labels (body, everyday life, and psyche) 
to each concept. The Wound- QoL can be scored sepa-
rately for each scale or by adding together the scales for 
a total score. PROMs that add scales together for a total 
score can be problematic because the concept of interest 
measured by the instrument may not be clear. The same 
is true for PROMs that score each scale separately if the 
scales are composed of item sets that ask about multiple 
concepts of interest (COI). For example, the body scale 
from the Wound- QoL has five items that measures a 
range of concepts, including pain, wound discharge and 
problems sleeping.28 Item sets that ask about multiple 
concepts are limited in their ability to measure change in 
specific issues. In the context of a clinical trial, such scales 
can mask effects of treatment (eg, when the direction 
and size of the scores vary by concept). The alternative 
approach is to design a set of independently functioning 
scales that each measure a unidimensional construct, for 
example, discharge, smell, sleep interference, and so on. 
An advantage of this approach is that respondent burden 
can be decreased as only the scales that are relevant to a 
particular research question or clinical scenario need to 
be used.
Currently, there is no comprehensive PROM designed 
using a modern psychometric approach covering all 
type of chronic wounds that are located anywhere on 
the body. The modern psychometric approach uses 
more sophisticated models and techniques than the 
traditional approach, providing more diagnostic details 
that aid in the refinement of scales that have interval 
(rather than ordinal) measurement properties.29 30 
This protocol describes an international collaboration 
between investigators in Canada, Denmark, the Nether-
lands, and the USA that aims to develop a new PROM 
(ie, the WOUND- Q) for patients with chronic wounds. 
The WOUND- Q will contain a comprehensive set of 
independently functioning scales designed to measure 
outcomes that matter to patients with any type of chronic 
wound, as well as scales to measure patients experience of 
wound care. We describe the mixed methods approach 
that we previously published in the development of other 
Q- Portfolio instruments.31–33
METhodS And AnAlySIS
Development of the WOUND- Q follows guidelines for 
PROM development outlined by the Scientific Advisory 
Committee of the Medical Outcomes Trust,34 the USA 
Food and Drug Administration,35 and the International 
Society for Pharmacoeconomics and Outcomes Research 
(ISPOR).36–38 We aim to develop a self- report instrument 
for adults (≥18 years old) with any type of chronic wound 
located anywhere on the body. Our goal is to develop a 
comprehensive set of independently functioning scales 
that measure COI important to patients and healthcare 
providers working in chronic wound care.
Our protocol covers a multi- phase mixed methods 
study that includes qualitative and quantitative lines of 
inquiry. Figure 1 shows the three main phases involved 
in the development of a PROM.33 These phases include 
iterative steps for item generation, item reduction, and 
psychometric validation. Careful adherence to the steps 
outlined in figure 1 will ensure the WOUND- Q fulfils 
minimum standards for acceptable psychometric prop-
erties described by the International Society for Quality 
of Life Research39 and the Consensus- based Standards 
for the Selection of Health Status Measurement Instru-
ments.40 41
Phase I: qualitative
We take a qualitative approach called interpretive descrip-
tion.42 43 In our context, this applied health services 
approach builds on existing wound- specific theoretical 
knowledge, clinical knowledge, and scientific research.
Sample
Participants are purposively sampled to include a hetero-
geneous sample that varies by the following characteris-
tics: age (18 years and older), gender, wound type, wound 
location, phase in the healing process, and risk of poor 
outcome (smokers and people with comorbid conditions 
such as diabetes and obesity). Participants are recruited 
in wound care clinics by a member of the healthcare team 
who obtain informed consent and pass contact details to 
a member of the research team to schedule interviews. 
Phase 1 involves sites from Canada (University of St 
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Figure 1 Flow diagram illustrating the multiphase mixed methods approach to the development of the WOUND- Q. QUAN, 
quantitative study component; QUAL, qualitative study component. Image reproduced from Wong Riff et al.33
Michael’s College, Toronto), Denmark (Odense Univer-
sity Hospital, Odense), the Netherlands (Catharina 
Hospital, Eindhoven; DaVinci Wound Clinic, Geldrop) 
and the USA (University of California, Los Angeles Berkley 
East Nursing Home, Berkley, and University of California, 
Los Angeles Medical Center, Santa Monica). Interviews 
are conducted face- to- face or by phone depending on 
participant preference and logistics for travel.
Concept elicitation
An interview guide (see box 1) is used to guide the inter-
views. Topics are informed by published wound- specific 
PROMs in the literature.13–15 25 28 Interviews are audio- 
recorded and transcribed verbatim. Interviews performed 
in Denmark and the Netherlands are translated into 
English by professional translators and are coded by the 
local research team members. Data are coded line- by- line 
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Box 1 Wound- Q interview guide
Wound
1. How did your wound originate? Probe: any comorbid diabetes and 
obesity.
2. Can you tell me about any wounds you’ve had in the past?
3. How was the healing process for you? Probe: haemostasis, inflam-
matory, proliferation, and remodelling/maturation.
Treatments
4. What treatment(s) have you had for your wound?
5. What was good/bad about the treatment(s)? Probe: side effects.
Symptoms
6. Can you describe any symptoms you experience? Probe: for exam-
ple, pain, odour and exudate.
7. Have symptoms changed over time? Probe: haemostasis, inflamma-
tion, proliferation and remodelling.
8. How bothersome are the symptoms?
9. How do you cope with the symptoms?
Recovery
10. How quickly did you recover?
11. What was the recovery process like? Probe: haemostasis, inflam-
mation, proliferation and remodelling.
12. Can you describe the early life impact? Probe: impact on physical, 
social, emotional and social life.
Appearance
13. How would you describe the appearance of your wound? Probe: 
for descriptive detail.
14. What do you dislike about the appearance of your wound?
15. How has your appearance changed? Probe: haemostasis, inflam-
mation, proliferation and remodelling.
16. Is there anything about the wound you wish looked different? 
Probe: for descriptive detail.
17. Do/did you ever hide or cover your wound? How do you do this?
Physical function
18. Does the wound create physical issues? Probe: for example, mobil-
ity and activity limitations.
19. How have these physical issues changed? Probe: haemostasis, in-
flammation, proliferation and remodelling.
Psychological well- being
20. How does your wound affect how you feel? Probe: happy, sad, anx-
ious, frustrated and self- conscious.
21. How does your wound affect how you feel about yourself? Probe: 
self- esteem, body image and confidence.
22. How have your emotions changed? Probe: haemostasis, inflamma-
tion, proliferation and remodelling.
Social life
23. What has it been like for you at home? Probe: partner, family and 
children.
24. Has the wound affected your usual activities? Probe: work/
education.
25. Do people ever comment on your wound? Probe: how did you react 
and how did you feel?
26. Are there things you would have liked to do but do not because of 
your wound?
27. Has anyone ever treated you differently because of your wound? 
Probe: friends, family and strangers.
Continued
Box 1 Continued
28. How else does your wound affect your social life? Probe: with 
friends, meeting new people and dating.
Experience of care
29. Who did you see at the hospital or clinic? Probe: doctor, nurse, 
receptionist and so on.
30. What are the people like who cared for you? Probe: friendly, made 
you feel comfortable, easy to talk to, listened to you, respectful and 
available.
31. What kind of verbal and written information did you receive? Probe: 
gave enough information, let you ask questions, answered your 
questions, information about recovery and treatment information.
32. What things could the healthcare team do differently to improve the 
care you received?
33. What should the perfect wound healing centre be like?
other questions
34. Is there anything I have not asked you that you think it is important 
for me to know?
whereby participant quotes are labelled with top- level 
domains, themes, and subthemes. Data are moved from 
Word to Excel for analysis. Participant characteristics are 
included in Excel to identify common and unique COI by 
participant characteristics (eg, wound type and location). 
Data analysis is done concurrently with data collection to 
add new concepts to the interview guide for probing with 
new participants. Sampling and recruitment continue 
until the point of saturation is reached, that is, no further 
new concepts are elicited from additional interviews.44
Rigour in the qualitative phase of the study is ensured 
by having one team member code the qualitative tran-
scripts and a second team member confirm the codes. 
Also, performing qualitative interviews and analysis at 
the same time makes it possible to add COIs important 
to participants to the interview guide in order to explore 
if the COIs are important to participants in subsequent 
interviews. Finally, peer debriefing is performed to verify 
the analysis of the qualitative data between team members 
who perform the coding, as well as with the full research 
team at the research team meeting described below.
Qualitative analysis leads to the refinement of a concep-
tual framework covering the main COI of people with 
chronic wounds. This framework is used to guide scale 
development.
Item generation
Participant quotes are used to create a comprehensive 
item pool. Items retain the language of participants as 
much as possible to ensure that scale content is easy to 
understand and resonates with patient experience. The 
item pool is sorted and analysed by levels of coding (ie, 
top- level domains and theme/subthemes) and partici-
pant characteristics (eg, wound type) to identify common 
and unique COI. The item pool is used to develop a 
comprehensive set of independently functioning scales 
that cover key aspects of the conceptual framework.
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Figure 2 Translation and cultural adaption steps for the WOUND- Q. Image reproduced from van Alphen et al.51 QUAN, 
quantitative study component; QUAL, qualitative study component.
Scale development
Scale development is informed by the Rasch Measure-
ment Theory (RMT) approach.30 45 In this approach, 
a pool of items that are reflective of the underlying 
constructs are derived from the qualitative data to create, 
for each scale, a conformable set of items that together 
map out a construct on a clinical hierarchy. Later in the 
study (phase II), the field- test data are analysed to see if 
the theorised construct is supported by the data, that is, 
do the data ‘fit’ the Rasch model. The pattern expected 
by the Rasch model follows a strict deterministic hierar-
chical ordering of items called Guttman scaling. When 
the data fit the Rasch model, the estimates derived from 
the model are considered appropriate, and it is legitimate 
to sum the items in a scale to obtain a total score that 
provides interval- level measurement. Scales are assigned 
appropriate instructions and a time frame for reporting. 
Each scale is assigned four or five labelled response 
options to keep them simple and in line with published 
guidelines.46
Research team meeting
After half the interviews are conducted and fully anal-
ysed, a full day face- to- face research team meeting is 
held to review the sample characteristics and data find-
ings in order to identify and address gaps and issues. At 
the meeting, wound care experts and the research team 
reviews codes, the item pool, and drafts scales that cover 
key aspects of the preliminary conceptual framework. 
Following this meeting, interviews and analysis continue 
until no new concepts are elicited from subsequent 
interviews.
Scale refinement
Scales are refined through multiple rounds of cognitive 
interviews47 48 using the ‘think aloud’ method.49 The aim 
is to determine content validity, that is whether scale 
content is relevant, comprehensive, and comprehend-
ible.41 Participants from the initial interviews are invited 
to review the scales (English versions). Interviews are 
audio- recorded, transcribed, and analysed line- by- line. 
Feedback on instructions, response options, and items 
are examined and used to revise the scales. Participants 
are encouraged to suggest missing issues that can be 
developed into items and added to scales.
Between rounds of cognitive interviews, the WOUND- Q 
is shown to experts for feedback. A web- based secure 
Research Electronic Data Capture (REDCap) survey is 
designed.50 An international sample of wound experts are 
emailed the link to access the survey and provide feed-
back on the instructions, response options, and items, 
and to suggest missing content that could be formed into 
new items. One reminder email is sent after 10 days. Feed-
back provided by experts is used to revise the scales.
Translations
The WOUND- Q is translated into Danish and Dutch 
following steps outlined in figure 2.51 Translations follow 
guidelines set forth by the ISPOR38 and the World Health 
Organization.52 These guidelines outline a rigorous 
process, previously used by our team,53 which involves two 
independent forward and one backward translation, an 
expert panel meeting, and a series of cognitive debriefing 
interviews with patients with chronic wounds. The aim is 
to create conceptually equivalent translations rather than 
literal translations. Producing more than one translation 
at the same time makes it possible to revise the items, 
instructions, and response options of the WOUND- Q 
based on feedback from the translation work and to 
harmonise the translations by comparing the Danish and 
Dutch with each other and with the English version.
Phase II: quantitative
The phase II field- test study begins with a pilot field- test 
sample to identify any final changes to the scales that are 
needed. Data from the first 250 participants are used to 
examine the psychometric performance of each scale.
Phase II involves collection of data from a large inter-
national sample of patients with wounds from sites in 
Canada (University of St Michael’s, Toronto), Denmark 
(Odense University Hospital, Odense), the Netherlands 
(Catharina Hospital, Eindhoven; DaVinci Wound Clinic, 
Geldrop; Erasmus Medical Center, Rotterdam) and the 
USA (Brigham and Women’s Hospital, Boston; Massa-
chusetts General Hospital Boston; University of Cali-
fornia, Los Angeles Berkley East Nursing Home, Berkley; 
University of California, Los Angeles Medical Center, 
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Santa Monica; MedStar Georgetown University Hospital, 
and MedStar Washington Hospital Center, Washington). 
Additional sites can be added if needed to ensure that 
the sample is large enough to explore how the items and 
scales function at the subgroup level.
Participants are aged 18 years and older, cognitively 
able to self- report, and have one or more chronic wounds 
anywhere on their body. A chronic wound is defined as 
a wound that has lasted 3 months or longer. Patients are 
recruited in hospital clinics by research assistants who 
obtain informed consent. Data are collected using tablets 
with data entered into databases. REDCap databases are 
hosted at Brigham and Women’s Hospital in Boston (for 
the Canadian and US data), and at Odense University 
Hospital (for Danish data). In the Netherlands, data are 
collected using the Castor database. Instructions with 
branching logic are used to ensure that only correct scales 
are administered to reduce respondent burden.
Data collected via separate databases are merged using 
IBM SPSS Statistics V.26 and are formatted appropri-
ately for RUMM2030 software for RMT analysis.54 The 
RMT analysis is used to refine each scale and to create 
the scoring algorithms that future users of the scales will 
require. A range of evidence is used to evaluate each 
item in a scale and examine how the items function as 
a set. Items that are the most effective in measuring the 
concepts measured by a scale are retained. Items that do 
not perform well are removed. Decisions based on the 
following set of statistical and graphical tests are used, 
and described in detail elsewhere30:
Thresholds for item response options: We examine thresh-
olds between response options (eg, ‘not at all’ and ‘a 
little’) to determine if a scales response categories are 
ordered, meaning that a ‘1’ on a 4- point scale sits lower 
down a continuum than a ‘2’ and so on. Items with disor-
dered thresholds may be dropped or recoded to ensure 
thresholds are properly ordered.
Item fit statistics: Three fit indicators are inspected 
including log residuals (item–person interaction), χ2 
values (item–trait interaction) and item characteristic 
curves. As a guide, ideal fit residuals are between −2.5 and 
+2.5, with Bonferroni adjusted χ2 values non- significant. 
The three fit indicators are interpreted together to decide 
which items to retain or drop.
Dependency: Residual correlations between pairs of items 
are inspected to identify high residual correlations as 
these can inflate reliability. For high residual correlations, 
a subtest is performed to determine the impact on the 
person separation index reliability statistic.
Targeting: The location of items is examined to deter-
mine if they are evenly spread over a reasonable range 
that matches the range of the construct reported by the 
sample. There should be minimal evidence of a floor or 
ceiling effect so that people with a wide variety of wounds 
at different stages of healing can be effectively measured 
over time.
Differential item functioning (DIF): DIF is examined using 
analysis of variance of item residuals to determine if 
individuals in subgroups (eg, sex, age, country and type 
of wound) respond differently to items despite the same 
measured trait level. We choose random samples to create 
equal- sized subgroups. Items with χ2 values significant 
after Bonferroni adjustment are split on the variable that 
evidences DIF, and the new and original person locations 
are correlated to examine impact on scoring.
Unidimensionality: We determine if all items in a scale 
measure the same, single latent construct using the 
method proposed by Smith based on independent 
t- tests.55
Person separation index: This reliability statistic measures 
error associated with the measurement of people in a 
sample and is similar in interpretation to Cronbach α.56
The minimum number of people needed to perform 
RMT analysis is 150 to have 50 respondents in each of 
3 class intervals for the χ2 analysis for tests of item fit.57 
To examine DIF by country will require 600 participants 
(n=150 per country). Our target is 250 per country to 
provide an even more robust scoring algorithms and 
normative scores.
In IBM SPSS Statistics V.26, traditional psychometric 
properties are examined including reliability (internal 
consistency), and construct validity. Once item reduc-
tion and psychometric validation of the field- test data 
is completed, the WOUND- Q will be made available for 
licensing through the Q- Portfolio website ( www. qport-
folio. org).
Subsequent phases
The phase II field- test study is currently ongoing and will 
be completed in 2020. We plan to seek grant funding to 
conduct a phase III study to examine further measurement 
properties on the item- reduced scales, such as concur-
rent validity (the degree to which scores on an instrument 
correlate with the Wound- QoL27), test- retest reliability, 
and to determine each scales’ ability to measure clinical 
change following wound treatment using anchor- based 
and distribution- based methods.58–60 These studies will 
be planned to reflect priorities identified by wound care 
teams and will use our international network of wound care 
centres.
Patient and public involvement
A limitation of our study is that patient involvement does 
not include membership in the research team. However, 
our approach to PROM development is patient oriented as 
we engage a large number of people with wounds, as well 
as clinical experts, in all stages of our research. Input from 
patients with chronic wounds are indispensable to ensuring 
that the scales are developed to measure outcomes that 
matter to them in the language they use so that the final 
instrument resonates. Patients who take part in qualitative 
interviews are invited to participate in the cognitive inter-
views as continuity of involvement ensures the scales accu-
rately reflect the experiences of patients living with chronic 
wounds. We recognise a limitation of using the same 
participants twice could be that others not involved in the 
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initial phase may provide new insights. Experts are involved 
at different steps in the research, including a research 
meeting half way through the qualitative interview phases, 
as well as during scale refinement phase. Involvement of 
experts ensures that the scales will cover all clinically rele-
vant outcomes and experiences of care.
Participants provide both written and oral consent before 
participating in an interview, and written consent for partic-
ipating in the field- test study. Participants in phase I are 
asked to discuss issues that can be sensitive, and they may 
experience distress. If necessary, participants will be put in 
touch with a healthcare provider at the recruiting site to 
obtain support. Participant data is de- identified during tran-
scription for the qualitative interviews. All data collected 
are kept secure and confidential following institution rules 
governing research data storage.
dISSEMInATIon
The WOUND- Q will be made available free of charge to 
all non- profit users. Our team will promote uptake of 
the WOUND- Q among stakeholder groups including 
researchers, healthcare practitioners, decision makers and 
policy makers. Our dissemination initiatives will include 
face- to- face interactions such as presentations at national 
and international meetings, as well as electronic and hard- 
copy media, including publication in journals that are 
valued and read by our target audiences. The Q- Portfolio 
website ( www. qportfolio. org) and social media (eg, Twitter 
and Instagram) will be used to spread awareness of the 
WOUND- Q to our network of followers.
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